Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,350,770 |
|
|||||
| News | - | ||||||
| Day High | 0.145 | Low High |
|||||
| Day Low | 0.13 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.006515 | -4.49% | 0.138485 | 11:17:28 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.14395 | 0.13 | 0.145 | 0.145 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 136 | 1,350,770 | US$ 0.139132 | US$ 187,936 | - | 0.0269 - 0.17 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:17:28 | 1,600 | US$ 0.138485 | USD |
Elite Pharmaceuticals Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 141.95M | 1.01B | 705.48M | 34.16M | 3.56M | 0.00 | 40.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Elite Pharmaceuticals (QB) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/27/2023 | 18:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/27/2023 | 17:58 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/27/2023 | 17:50 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/16/2023 | 06:32 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with.. |
| 9/25/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/07/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/14/2023 | 16:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/31/2023 | 15:20 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K.. |
| 7/17/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/29/2023 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/29/2023 | 15:43 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.155 | 0.16075 | 0.13 | 0.152444 | 1,488,477 | -0.01652 | -10.65% |
| 1 Month | 0.117 | 0.17 | 0.10 | 0.1422182 | 1,560,195 | 0.02149 | 18.36% |
| 3 Months | 0.0899 | 0.17 | 0.05605 | 0.1223122 | 1,248,965 | 0.04859 | 54.04% |
| 6 Months | 0.035 | 0.17 | 0.0301 | 0.0951109 | 1,179,628 | 0.10349 | 295.67% |
| 1 Year | 0.039 | 0.17 | 0.0269 | 0.0815514 | 761,735 | 0.09949 | 255.09% |
| 3 Years | 0.048 | 0.17 | 0.023 | 0.0598752 | 771,933 | 0.09049 | 188.51% |
| 5 Years | 0.0802 | 0.17 | 0.023 | 0.0680083 | 781,096 | 0.05829 | 72.67% |
Elite Pharmaceuticals (QB) Description
| Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. |
